Mexico warns of falsified transplant medicine

Mexico's Federal Commission for the Protection against Sanitary Risks (Cofepris) has issued an alert about a falsified version of Limustin, an immunosuppressant drug used in transplant medicine.

The counterfeit copies of Landsteiner Scientific's tacrolimus product should not be used as they could put patients at risk of serious side effects and treatment failure, according to the regulatory authority.

The falsified medicine has a fictitious lot number 129B0219 and the expiration date DEC23, and has a number of other discrepancies with the genuine product.

The primary packaging is translucent in colour and the pictogram of a pregnant woman obstructs the text, and the lettering one security seal are in English and blurred. Inside the primary packaging there is a cotton wick, and capsules are white and blue, differing from the genuine product.

If a distributor or pharmacy has the fake product in stock, they must quarantine it and alert the authorities.